| Q35323821 | "Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder |
| Q58778183 | 'A no means no'--measuring depression using a single-item question versus Hospital Anxiety and Depression Scale (HADS-D) |
| Q47285127 | A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders |
| Q35833294 | A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder |
| Q89086815 | A 6-year longitudinal study of predictors for suicide attempts in major depressive disorder |
| Q46101552 | A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar Disorder |
| Q36253396 | A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric Population |
| Q38779921 | A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. |
| Q35965634 | A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder |
| Q42751743 | A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report |
| Q36843480 | A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice |
| Q36370589 | A comparison of the clinical characteristics of women with recurrent major depression with and without suicidal symptomatology |
| Q48064476 | A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate |
| Q48627803 | A medication assessment tool to evaluate prescribers' adherence to evidence-based guidelines in bipolar disorder |
| Q50110124 | A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania |
| Q33925510 | A population-based longitudinal study of risk factors for suicide attempts in major depressive disorder |
| Q38547352 | A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. |
| Q38212591 | A systematic and critical review of model-based economic evaluations of pharmacotherapeutics in patients with bipolar disorder |
| Q26866464 | A systematic review and meta-analysis of premature mortality in bipolar affective disorder |
| Q40842714 | Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals |
| Q47629882 | Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index |
| Q99240549 | Addressing Major Health Disparities Related to Coronavirus for People With Behavioral Health Conditions Requires Strength-Based Capacity Building and Intentional Community Partnership |
| Q35179053 | Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat |
| Q51841194 | Adolescent inpatient psychiatric admission rates and subsequent one‐year mortality in England: 1998–2004 |
| Q36759325 | Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker. |
| Q48641811 | Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder |
| Q75195737 | Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics |
| Q97418693 | Advances toward precision medicine for bipolar disorder: mechanisms & molecules |
| Q45035278 | Adverse events associated with psychotropic treatment in African American children and adolescents. |
| Q51933996 | African-American participants in a bipolar disorder registry: clinical and treatment characteristics. |
| Q35629702 | Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures |
| Q33835333 | Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care |
| Q35067926 | Ala54Thr fatty acid-binding protein 2 (FABP2) polymorphism in recurrent depression: associations with fatty acid concentrations and waist circumference. |
| Q34661499 | Almost all antipsychotics result in weight gain: a meta-analysis |
| Q46561258 | Alpha-thalassemias and bipolar disorders: a genetic link? |
| Q52565175 | An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics. |
| Q40349260 | Anorexia nervosa in males: excess mortality and psychiatric co-morbidity in 609 Swedish in-patients |
| Q92861675 | Anti-Suicidal Efficacy of Repetitive Transcranial Magnetic Stimulation in Depressive Patients: A Retrospective Analysis of a Large Sample |
| Q43495027 | Antidepressant medication prevents suicide in depression |
| Q57260313 | Antipsychotics and Associated Risk of Out-of-Hospital Cardiac Arrest |
| Q36356694 | Antisocial personality disorder and borderline symptoms are differentially related to impulsivity and course of illness in bipolar disorder |
| Q36677643 | Anxiety disorders and bipolar disorder: a review |
| Q38378743 | Are medical comorbid conditions of bipolar disorder due to immune dysfunction? |
| Q33565044 | Are there developmentally limited forms of bipolar disorder? |
| Q36808054 | Aripiprazole: pharmacology and evidence in bipolar disorder |
| Q37356508 | Assessment and treatment of suicide risk in bipolar disorders |
| Q55443448 | Association of viral hepatitis and bipolar disorder: a nationwide population-based study. |
| Q21132062 | Attempted suicide in bipolar disorder: risk factors in a cohort of 6086 patients |
| Q38297860 | Balancing benefits and harms of treatments for acute bipolar depression |
| Q36755314 | Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials |
| Q37980570 | Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness |
| Q38023889 | Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium. |
| Q48343394 | Bipolar II disorder in patients with a current diagnosis of recurrent depression |
| Q92426910 | Bipolar depression: a major unsolved challenge |
| Q37952587 | Bipolar depression: an evidence-based approach |
| Q47194159 | Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease |
| Q37083025 | Bipolar disorder and suicide: research synthesis and clinical translation |
| Q37207249 | Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden |
| Q35236977 | Bipolar disorder--methodological problems and future perspectives |
| Q35940844 | Bipolar disorder: a national health concern. |
| Q104077152 | Bipolar disorders |
| Q51887291 | Body composition in psychotic disorders: a general population survey. |
| Q38979799 | Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania |
| Q59792277 | Bringing an Effective Behavioral Weight Loss Intervention for People With Serious Mental Illness to Scale |
| Q37154793 | Bupropion extended-release for depressive disorders |
| Q91589676 | C-reactive protein concentration in bipolar disorder: association with genetic variants |
| Q36594531 | Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls. |
| Q36401142 | Can bipolar disorder be viewed as a multi-system inflammatory disease? |
| Q36532159 | Can body mass index help predict outcome in patients with bipolar disorder? |
| Q36077336 | Cardiologic side effects of psychotropic drugs. |
| Q37788533 | Cardiovascular aspects of antipsychotics |
| Q36108130 | Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States |
| Q46158848 | Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study |
| Q36870063 | Cardiovascular effects of antipsychotics |
| Q35313130 | Cardiovascular morbidity and mortality in bipolar disorder. |
| Q36810120 | Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden |
| Q49611619 | Cardiovascular risk and bipolar disorder: factors associated with a positive coronary calcium score in patients with bipolar disorder type 1. |
| Q51864590 | Cardiovascular risk assessment and management in mental health clients: whose role is it anyway? |
| Q50748723 | Cause-specific mortality of psychiatric inpatients and outpatients in a general hospital in Korea. |
| Q80464661 | Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications |
| Q45751300 | Characteristics of bipolar disorder patients given antidepressants |
| Q38731705 | Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis |
| Q34432313 | Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa? |
| Q34026166 | Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder |
| Q35831460 | Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder |
| Q39143877 | Clinical and neuropsychological characteristics of euthymic bipolar patients having a history of severe suicide attempt |
| Q38097098 | Clinical assessment and crisis intervention for the suicidal bipolar disorder patient |
| Q92061330 | Clinical use of lithium salts: guide for users and prescribers |
| Q33908803 | Co-morbidity in Bipolar Disorder: A Retrospective Study. |
| Q38194541 | Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview |
| Q24202558 | Collaborative care approaches for people with severe mental illness |
| Q24203981 | Collaborative care approaches for people with severe mental illness |
| Q36138866 | Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey |
| Q37100104 | Comparison of mania patients suitable for treatment trials versus clinical treatment |
| Q81489929 | Considering wellness in managing patients with bipolar disorder |
| Q36955359 | Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder |
| Q35629112 | Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder |
| Q38650096 | Depression and Its Correlates Among Brazilian Immigrants in Massachusetts, USA. |
| Q34112594 | Depression and cancer mortality: a meta-analysis. |
| Q34130495 | Depression and cardiovascular disease: an update on how course of illness may influence risk |
| Q34786778 | Depression as a risk factor for non-suicide mortality in the elderly |
| Q40042366 | Depressive symptomatology in relation to 10-year (2004-2014) acute coronary syndrome incidence; the moderating role of diet and financial status |
| Q28066354 | Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation |
| Q91593851 | Differential effects on neurodevelopment of FTO variants in obesity and bipolar disorder suggested by in silico prediction of functional impact: An analysis in Mexican population |
| Q48090581 | Distinguishing bipolar II depression from unipolar major depressive disorder: Differences in heart rate variability |
| Q37979673 | Early intervention for bipolar disorder: current imperatives, future directions |
| Q35115967 | Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006. |
| Q37349876 | Effects of acute aerobic exercise on neural correlates of attention and inhibition in adolescents with bipolar disorder. |
| Q39528056 | Effects of ankyrin 3 gene risk variants on brain structures in patients with bipolar disorder and healthy subjects |
| Q61807187 | Elevated Familial Cardiovascular Burden Among Adolescents With Familial Bipolar Disorder |
| Q36502629 | Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? |
| Q58959450 | Epidemiology of Suicide and Attempted Suicide |
| Q57483556 | Epidemiology of Suicide and the Psychiatric Perspective |
| Q38113575 | Epidemiology of suicide in bipolar disorders: a systematic review of the literature |
| Q91160301 | Epidemiology of suicide: recent developments |
| Q37424330 | Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder |
| Q27021810 | Epigenetic mechanisms in mood disorders: targeting neuroplasticity |
| Q35481734 | Evaluation of left ventricular systolic and diastolic functions in bipolar patients during lithium therapy |
| Q36134990 | Evidence for accelerated vascular aging in bipolar disorder. |
| Q91386045 | Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI |
| Q34296938 | Evidence-based options for treatment-resistant adult bipolar disorder patients |
| Q98462800 | Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan |
| Q37419844 | Excess mortality due to depression and anxiety in the United States: results from a nationally representative survey |
| Q36957061 | Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services |
| Q34571634 | Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden |
| Q38262469 | Exercise therapy improves both mental and physical health in patients with major depression |
| Q45350830 | Expression of matrix metalloproteinases in patients with bipolar disorder |
| Q44841212 | Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder |
| Q35855984 | Fluctuating capacity and advance decision-making in Bipolar Affective Disorder - Self-binding directives and self-determination. |
| Q64039164 | From Clinical Research to Clinical Practice: A 4-Year Review of Ziprasidone |
| Q53420692 | Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15. |
| Q37042954 | Gender differences in health-related quality of life in patients with bipolar disorder |
| Q85789509 | Gene therapy for psychiatric disorders |
| Q37226546 | Genome-wide association study of suicide attempts in mood disorder patients |
| Q46696102 | Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol |
| Q47997952 | Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. |
| Q55082082 | Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. |
| Q30808402 | Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China |
| Q37042160 | Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial |
| Q58196968 | Healthy lifestyle intervention for people with severe mental disorders |
| Q34071117 | History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study |
| Q46747918 | Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. |
| Q35203604 | Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. |
| Q101476021 | Identification of candidate genetic variants and altered protein expression in neural stem and mature neural cells support altered microtubule function to be an essential component in bipolar disorder |
| Q44944054 | Illness-course modulates suicidality-related prefrontal gray matter reduction in women with bipolar disorder |
| Q38129717 | Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications |
| Q37128936 | Impact of medical comorbidity on medication management of schizophrenia. |
| Q37719817 | Impaired frontothalamic circuitry in suicidal patients with depression revealed by diffusion tensor imaging at 3.0 T. |
| Q91360526 | Improving monitoring for metabolic syndrome using audit |
| Q48504214 | Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population-based study |
| Q50706849 | Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania. |
| Q39623722 | Increased mortality among people with anxiety disorders: total population study |
| Q57061922 | Indicated preventive interventions for depression in children and adolescents: A meta-analysis and meta-regression |
| Q36374128 | Inequalities in physical comorbidity: a longitudinal comparative cohort study of people with severe mental illness in the UK. |
| Q96305438 | Inflammatory and vascular correlates of mood change over 8 weeks |
| Q50571436 | Insulin resistance in bipolar disorder: relevance to routine clinical care. |
| Q38261404 | International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. |
| Q28084519 | Investigating the mechanism(s) underlying switching between states in bipolar disorder |
| Q28085253 | Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies |
| Q22241259 | Is sex important? Gender differences in bipolar disorder |
| Q38068616 | Is there a clinical prodrome of bipolar disorder? A review of the evidence |
| Q37559823 | Ketamine as antidepressant? Current state and future perspectives |
| Q30586696 | Label-free, live optical imaging of reprogrammed bipolar disorder patient-derived cells reveals a functional correlate of lithium responsiveness. |
| Q60633611 | Les anomalies du sommeil peuvent-elles participer au risque cardio-vasculaire des troubles bipolaires ? |
| Q37254536 | Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities. |
| Q47679505 | Life expectancy after the first suicide attempt |
| Q34796516 | Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries |
| Q41110099 | Life expectancy in bipolar disorder |
| Q22253024 | Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication |
| Q33813546 | Lifetime manic spectrum episodes and all-cause mortality: 26-year follow-up of the NIMH Epidemiologic Catchment Area Study |
| Q38955537 | Lithium Pharmacogenetics: Where Do We Stand? |
| Q95840818 | Lithium Treatment Over the Lifespan in Bipolar Disorders |
| Q28076935 | Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations |
| Q40908410 | Lithium treatment and cancer incidence in bipolar disorder |
| Q33886093 | Long-acting risperidone: a review of its role in the treatment of bipolar disorder |
| Q21135551 | Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden |
| Q37008781 | Long-term risk of myocardial infarction and stroke in bipolar I disorder: A population-based Cohort Study |
| Q37675302 | Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment |
| Q99584412 | Longitudinal trajectories of brain age in young individuals at familial risk of mood disorder |
| Q34350376 | Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease |
| Q38362255 | Lurasidone: a review of its use in adult patients with bipolar I depression |
| Q36902005 | Maintenance treatment in bipolar disorder: a focus on aripiprazole |
| Q55365950 | Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD). |
| Q38859885 | Managing comorbid obesity and depression through clinical pharmacotherapies |
| Q35792803 | Mandatory implementation of NICE Guidelines for the care of bipolar disorder and other conditions in England and Wales |
| Q37631787 | Mania and mortality: why the excess cardiovascular risk in bipolar disorder? |
| Q51932078 | Mania in the Swedish Twin Registry: criterion validity and prevalence. |
| Q37426682 | Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder |
| Q37484777 | Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders |
| Q48564651 | Matrix metalloproteinase-9 gene and bipolar mood disorder |
| Q33835811 | Medical and substance use comorbidity in bipolar disorder |
| Q35236970 | Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities |
| Q50627364 | Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). |
| Q37113810 | Medical burden in late-life bipolar and major depressive disorders |
| Q34034971 | Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome |
| Q34415678 | Mental illness and reduction of gun violence and suicide: bringing epidemiologic research to policy |
| Q36940652 | Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder |
| Q46152573 | Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. |
| Q64085328 | Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives |
| Q38150605 | Metabolic syndrome and major depression |
| Q37385194 | Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap |
| Q36400968 | Metabolic syndrome in bipolar disorders |
| Q48076370 | Metabolic syndrome in first-time hospitalized patients with depression: a 1-year follow-up study |
| Q45040992 | Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics |
| Q36310319 | Metabolism, lifestyle and bipolar affective disorder |
| Q40491070 | Mind the Gap: Developing an Integrated Behavioral Health Home to Address Health Disparities in Serious Mental Illness |
| Q34156483 | Misdiagnosis of bipolar disorder |
| Q36391143 | Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids |
| Q48860333 | Mitochondrial respiratory chain activity in an animal model of mania induced by ouabain |
| Q30375478 | Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. |
| Q26827615 | Molecular and genetic basis of depression |
| Q37089323 | Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study |
| Q33889282 | Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. |
| Q37327349 | Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders |
| Q47973002 | Morbidity in Depressive Disorders |
| Q89933221 | Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study |
| Q46337794 | Mortality in offspring of mothers with psychotic disorder |
| Q46798982 | Mortality of 403 patients with mood disorders 48 to 52 years after their psychiatric hospitalisation |
| Q36022514 | Mortality, Rehospitalisation and Violent Crime in Forensic Psychiatric Patients Discharged from Hospital: Rates and Risk Factors |
| Q35073653 | Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. |
| Q46626315 | Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder |
| Q36755750 | Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works. |
| Q28246161 | No health without mental health |
| Q38416496 | Non-invasive vascular imaging is associated with cardiovascular risk factors among adolescents with bipolar disorder |
| Q37387774 | Nursing children and adolescents with bipolar disorder: assessment, diagnosis, treatment, and management |
| Q26771735 | Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review |
| Q51427912 | Obesity and metabolic syndrome in Brazilian patients with bipolar disorder. |
| Q36751327 | Obesity and the three-year longitudinal course of bipolar disorder |
| Q38035727 | Obesity in bipolar disorder: an overview |
| Q29395337 | Options for Pharmacological Treatment of Refractory Bipolar Depression |
| Q37960632 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review |
| Q24626094 | Osteoprotegerin levels in patients with severe mental disorders |
| Q38083305 | Overview of antidepressant treatment of bipolar depression |
| Q36269305 | Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health |
| Q33567174 | Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain |
| Q50772250 | Perceived health risks, attitude and readiness to quit tobacco among euthymic bipolar disorder patients in regular contact with mental health services: an exploratory study from India. |
| Q41226189 | Personal experience: Suicide and psychiatric care - a lament |
| Q38809317 | Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients. |
| Q35040884 | Pharmacogenetic aspects of bipolar disorder |
| Q38097534 | Pharmacogenomics of bipolar disorder |
| Q88427167 | Pharmacological treatment of adult bipolar disorder |
| Q33770623 | Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China |
| Q33942312 | Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness |
| Q34623350 | Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. |
| Q33586155 | Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study |
| Q39077270 | Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application |
| Q48248419 | Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study |
| Q44281926 | Post-discharge suicides of inpatients with bipolar disorder in Finland |
| Q36024686 | Predicting future suicide attempts among depressed suicide ideators: a 10-year longitudinal study |
| Q96129310 | Prediction of depression cases, incidence, and chronicity in a large occupational cohort using machine learning techniques: an analysis of the ELSA-Brasil study |
| Q36443736 | Predictors of lithium response in bipolar disorder |
| Q34024177 | Preliminary findings regarding overweight and obesity in pediatric bipolar disorder |
| Q35496330 | Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders |
| Q36078546 | Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders |
| Q35708859 | Preventing mental illness: closing the evidence-practice gap through workforce and services planning |
| Q33578843 | Prospective longitudinal course of aggression among adults with bipolar disorder |
| Q63976701 | Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center |
| Q40260814 | Psychiatric disorder and work life: A longitudinal study of intra-generational social mobility |
| Q35613754 | Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? |
| Q38160399 | Purging disorder: a pathway to death? A review of 11 cases |
| Q37284060 | Purinergic signaling and energy homeostasis in psychiatric disorders |
| Q91905914 | QT and P-wave dispersion during the manic phase of bipolar disorder |
| Q34629599 | Quality of care for heart failure among disabled Medicaid recipients with and without severe mental illness |
| Q35789305 | Quality of medical care and excess mortality in psychiatric patients--a nationwide register-based study in Sweden |
| Q37429709 | Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies |
| Q38004093 | Quetiapine: a review of its use in the management of bipolar depression |
| Q37807087 | REVIEW: Patient, Treatment, and Systems‐Level Factors in Bipolar Disorder Nonadherence: A Summary of the Literature |
| Q38671397 | Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months |
| Q33757855 | Randomised controlled trial of the clinical and cost effectiveness of a specialist team for managing refractory unipolar depressive disorder |
| Q50594980 | Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders. |
| Q48008861 | Randomized, controlled trial of a brief family-centred care programme for hospitalized patients with bipolar disorder and their family caregivers |
| Q38125216 | Recognition of bipolar disorder type I before the first manic episode: challenges and developments. |
| Q37886927 | Recovered or dead? A Swedish study of 321 persons surveyed as severely mentally ill in 1995/96 but not so ten years later |
| Q60930724 | Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning |
| Q50747676 | Reliability of self-reported tobacco use in bipolar disorder: an exploratory study of euthymic patients visiting a tertiary care hospital in India. |
| Q36165233 | Remission from depression : a review of venlafaxine clinical and economic evidence |
| Q33712371 | Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder |
| Q26849474 | Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness |
| Q90297280 | Risk Factors for Recent Suicide Attempts in Major Depressive Disorder Patients in China: Results From a National Study |
| Q38775446 | Risk factors for early cardiovascular mortality in patients with bipolar disorder |
| Q90749239 | Risk factors for suicide in bipolar disorder: a cohort study of 12 850 patients |
| Q37255608 | Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis. |
| Q46813788 | Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects |
| Q36990595 | Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up |
| Q45044484 | Risk of suicide attempt and suicide death in patients treated for bipolar disorder |
| Q36773267 | Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. |
| Q38808320 | Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions |
| Q48063920 | SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM. |
| Q35940851 | Safety considerations in pharmacotherapy of bipolar disorder |
| Q34626687 | Season of birth is associated with adult body mass index in patients with bipolar disorder |
| Q37810765 | Second-generation antipsychotics in major depressive disorder: update and clinical perspective |
| Q33606886 | Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns. |
| Q90478956 | Sensitivity to Climate and Weather Changes in Euthymic Bipolar Subjects: Association With Suicide Attempts |
| Q55322969 | Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom. |
| Q30626205 | Sex differences in mania phenotype and ethanol consumption in the lateral hypothalamic kindled rat model. |
| Q38182163 | Sex differences in rates of obesity in bipolar disorder: postulated mechanisms |
| Q53803131 | Sexual Risk Behavior, Sexual Violence, and HIV in Persons With Severe Mental Illness in Uganda: Hospital-Based Cross-Sectional Study and National Comparison Data. |
| Q34964892 | Sexually dimorphic, developmental, and chronobiological behavioral profiles of a mouse mania model |
| Q34002763 | Significance of cigarette smoking among youths with bipolar disorder |
| Q44812007 | Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China |
| Q48483148 | Sociodemographic, psychiatric and somatic risk factors for suicide: a Swedish national cohort study |
| Q38672608 | Solar insolation in springtime influences age of onset of bipolar I disorder |
| Q38049775 | Spanish consensus on physical health of patients with bipolar disorder |
| Q36593276 | Stability of symptoms across major depressive episodes in bipolar disorder |
| Q33985405 | Strategies for monitoring outcomes in patients with bipolar disorder |
| Q33786288 | Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders |
| Q38006985 | Suicidal behavior in war veterans |
| Q35129379 | Suicidal behaviour in bipolar disorder: risk and prevention |
| Q33836848 | Suicidal behaviour in mood disorders--who, when, and why? |
| Q38753407 | Suicide Rates After Discharge From Psychiatric Facilities: A Systematic Review and Meta-analysis |
| Q35184467 | Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). |
| Q38629803 | Suicide attempts in bipolar disorders: comprehensive review of 101 reports. |
| Q44085213 | Suicide in a large population of former psychiatric inpatients |
| Q44560054 | Suicide in bipolar I disorder in Finland: psychological autopsy findings from the National Suicide Prevention Project in Finland |
| Q36525750 | Suicide in bipolar disorder: Risks and management. |
| Q39181704 | Suicide in bipolar disorder: characteristics and subgroups |
| Q38084340 | Suicide in prisoners with bipolar disorder and other psychiatric disorders: a systematic review. |
| Q48720983 | Suicide mortality of suicide attempt patients discharged from emergency room, nonsuicidal psychiatric patients discharged from emergency room, admitted suicide attempt patients, and admitted nonsuicidal psychiatric patients |
| Q38189070 | Suicide prevention as a prerequisite for recovery from severe mental illness |
| Q34480356 | Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes |
| Q36034676 | Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. |
| Q64053057 | Teaching psychiatry to large groups in society |
| Q47628124 | The Behavioral Approach System (BAS) Model of Vulnerability to Bipolar Disorder: Evidence of a Continuum in BAS Sensitivity across Adolescence. |
| Q34530223 | The Drosophila ETV5 Homologue Ets96B: Molecular Link between Obesity and Bipolar Disorder |
| Q35649658 | The Use of Cannabis as a Predictor of Early Onset of Bipolar Disorder and Suicide Attempts |
| Q34230095 | The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. |
| Q38040453 | The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? |
| Q35629735 | The association between antipsychotic agents and the risk of myocardial infarction: a systematic review |
| Q37784203 | The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. |
| Q34644143 | The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample |
| Q31029367 | The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England |
| Q37195491 | The burden of mental disorders |
| Q35167517 | The burden of obesity among adults with bipolar disorder in the United States |
| Q35054681 | The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited |
| Q37460196 | The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism |
| Q22241708 | The course of bipolar disorder |
| Q35908560 | The development of depressive symptoms during medical internship stress predicts worsening vascular function |
| Q38697937 | The development of lurasidone for bipolar depression |
| Q34538100 | The effect of antidepressants on lipid homeostasis: a cardiac safety concern? |
| Q46535632 | The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder |
| Q38132709 | The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study |
| Q37822483 | The epidemiology of excess mortality in people with mental illness |
| Q36715578 | The expression of bipolar spectrum psychopathology in daily life |
| Q37920920 | The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness |
| Q38076457 | The impact of child sexual abuse on the course of bipolar disorder: a systematic review |
| Q36195205 | The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. |
| Q38243753 | The impact of psychopharmacology on contemporary clinical psychiatry |
| Q35090232 | The increasing burden of depression |
| Q48561637 | The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder |
| Q38190416 | The interface of physical and mental health. |
| Q47380153 | The longitudinal association between temperament and physical activity in young children |
| Q38767618 | The management of bipolar disorder |
| Q35841353 | The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? |
| Q47775418 | The poor general health of the severely mentally ill: impact of schizophrenic diagnosis |
| Q38012489 | The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders |
| Q35844284 | The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models |
| Q48587628 | The risk factors for elderly patients with bipolar disorder having cerebral infarction |
| Q28236713 | The role of atypical antipsychotics in bipolar depression and anxiety disorders |
| Q33347664 | The role of genetic variation in the causation of mental illness: an evolution-informed framework |
| Q26800426 | The role of inflammation in suicidal behaviour |
| Q26740214 | The role of sleep in bipolar disorder |
| Q42767670 | The thrifty psychiatric phenotype |
| Q33985400 | Tools to improve differential diagnosis of bipolar disorder in primary care |
| Q37588877 | Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function |
| Q36786370 | Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder |
| Q37280843 | Treatment of bipolar disorder: new perspectives |
| Q34969649 | Treatment research in bipolar disorder: issues and recommendations |
| Q37563192 | Urdu translation of the Hamilton Rating Scale for Depression: Results of a validation study |
| Q35778894 | Validity and reliability of chronic tic disorder and obsessive-compulsive disorder diagnoses in the Swedish National Patient Register |
| Q37916681 | Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden |
| Q35754658 | Vascular function is not impaired early in the course of bipolar disorder |
| Q34017305 | Vascular mortality in participants of a bipolar genomics study |
| Q36597036 | Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression study |
| Q51899586 | Visual impairment in persons with psychotic disorder. |
| Q48671243 | Wet minds, dry minds, and the future of psychiatry as a science |
| Q50591643 | Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? |
| Q35577365 | Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles |
| Q50740011 | [Annual costs of bipolar disorders in Germany]. |
| Q79904986 | [Bipolar disorder and suicide] |
| Q86086572 | [Bipolar disorders and somatic comorbidities: a focus on metabollic syndrome, diabetes and cardiovascular disease] |
| Q81442160 | [How much general medical competency does a psychiatrist need?] |
| Q86086568 | [Predominant polarity, mixed states and suicide] |
| Q82829638 | [Severe depression : morbidity-mortality and suicide] |
| Q57698064 | Évolution du trouble bipolaire |